Medicines labeled for the same conditions
Alternatives to amlodipine and benazepril
62 other medicines are given the same way (oral) and in the same FDA class as amlodipine and benazepril or labeled mainly for the same use (high blood pressure); 21 are in its class, calcium channel blockers: diltiazem, lisinopril, nifedipine, enalapril and 17 more; the others include 9 beta-adrenergic blockers, 8 thiazide diuretics and 7 angiotensin 2 receptor blockers (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $0.0254 per lisinopril 20 mg tablet (what pharmacies paid in the NADAC survey; strengths differ).
Which medicines are labeled for the same conditions as amlodipine and benazepril?
The first 24 of the 62, the same class first. High blood pressure lists all 88 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (oral) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Amlodipine and benazeprilcalcium channel blocker | this medicine | 16 labelers | $0.114 per unit 10-20 mg | Yes | No current entry |
| Diltiazemcalcium channel blocker · same class | High blood pressure | 42 labelers | $0.144 per capsule 24h ER(cd) 120 mg capsule | No | A presentation being discontinued |
| Lisinoprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 36 labelers | $0.0254 per tablet 20 mg tablet | Yes | No current entry |
| Nifedipinedihydropyridine calcium channel blocker · same class | High blood pressure | 32 labelers | $0.130 per tablet 30 mg tablet | No | No current entry |
| Enalaprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 29 labelers | $0.0664 per tablet 10 mg tablet | Yes | No current entry |
| Hydrochlorothiazide and lisinoprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 27 labelers | $0.0293 per tablet 10-12.5 mg tablet | Yes | No current entry |
| Verapamilcalcium channel blocker · same class | High blood pressure | 24 labelers | $0.191 per tablet 180 mg tablet | No | A presentation being discontinued |
| Ramiprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 17 labelers | $0.0707 per capsule 10 mg capsule | Yes | No current entry |
| Felodipinedihydropyridine calcium channel blocker · same class | High blood pressure | 14 labelers | $0.123 per tablet 5 mg tablet | No | No current entry |
| Captoprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 13 labelers | $0.228 per tablet 12.5 mg tablet | Yes | No current entry |
| Quinaprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 9 labelers | n/a | Yes | In shortage |
| Fosinoprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 7 labelers | $0.154 per tablet 10 mg tablet | Yes | No current entry |
| Nicardipinedihydropyridine calcium channel blocker · same class | High blood pressure | 9 labelers | $1.12 per capsule 20 mg capsule | No | No current entry |
| Trandolaprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 5 labelers | $0.157 per tablet 1 mg tablet | Yes | No current entry |
| Hydrochlorothiazide and quinaprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 4 labelers | n/a | Yes | In shortage |
| Nisoldipinedihydropyridine calcium channel blocker · same class | High blood pressure | 1 labeler | $5.24 per tablet 34 mg tablet | No | No current entry |
| Enalapril and hydrochlorothiazideangiotensin converting enzyme inhibitor · same class | High blood pressure | 2 labelers | $0.209 per tablet 10-25 mg tablet | Yes | No current entry |
| Isradipinedihydropyridine calcium channel blocker · same class | High blood pressure | 3 labelers | $1.70 per capsule 5 mg capsule | No | No current entry |
| Captopril and hydrochlorothiazideangiotensin converting enzyme inhibitor · same class | High blood pressure | 1 labeler | n/a | Yes | No current entry |
| Fosinopril and hydrochlorothiazideangiotensin converting enzyme inhibitor · same class | High blood pressure | 2 labelers | $0.634 per tablet 10-12.5 mg tablet | Yes | No current entry |
| Trandolapril and verapamilcalcium channel blocker · same class | High blood pressure | 1 labeler | n/a | Yes | No current entry |
| Perindoprilangiotensin converting enzyme inhibitor · same class | High blood pressure | 1 labeler | $0.495 per tablet 4 mg tablet | Yes | No current entry |
| Metoprololbeta-adrenergic blocker | High blood pressure | 64 labelers | $0.085 per tablet 100 mg tablet | No | A presentation being discontinued |
| Propranololbeta-adrenergic blocker | High blood pressure | 38 labelers | $0.0493 per tablet 20 mg tablet | No | In shortage |
| Losartanangiotensin 2 receptor blocker | High blood pressure | 44 labelers | $0.0327 per tablet 50 mg tablet | Yes | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Amlodipine and benazepril: the full record
- label, generics, price, shortages, recalls